Breaking News Headlines Today | Ground News

See every side of every news story

hitconsultant.net image

News from hitconsultant.net

Ground News rates hitconsultant.net’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, AllSides, and Media Bias/Fact Check.

Is hitconsultant.net credible or reliable? Our Factuality score answers both of those questions. When it comes to hitconsultant.net, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about hitconsultant.net

Where is hitconsultant.net located?hitconsultant.net's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top hitconsultant.net News

Sword Acquires Kaia Health, Extending Its Lead in AI Health and Expanding Reach to 100 Million People Worldwide

Startups · Germany

Sword Acquires Kaia Health, Extending Its Lead in AI Health and Expanding Reach to 100 Million People Worldwide

Coverage: 5 sources

$285M acquisition expands Sword in the U.S. and establishes a major foothold in Germany’s 70M-plus covered digital care market...See the Story

Wisp Acquires Sexual Health Platform TBD Health

Wisp Acquires Sexual Health Platform TBD Health

100% Center coverage: 2 sources

This is Wisp’s first acquisition, for which the terms of the deal were not disclosed. It allows the company to expand into providing in-person care to complement its virtual support. The post Wisp Acquires Sexual Health Platform TBD Health appeared first on MedCity News.See the Story

Biology: Cellares Raises $257M to Industrialize Cell Therapy

IPO · United States

Biology: Cellares Raises $257M to Industrialize Cell Therapy

What You Should Know The News: Cellares has raised $257M in Series D financing, bringing its total capital to $612 million. The round was co-led by BlackRock and Eclipse.The Tech: Cellares is building the world’s first IDMO (Integrated Development and Manufacturing Organization). Its Cell Shuttle and Cell Q platforms fully automate the manufacturing and quality control of cell therapies, replacing “artisanal” manual processes.The Scale: The comp…See the Story

Breaking News Topics Related to hitconsultant.net